DEFINING RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY: INSIGHTS FROM THE EVALUATION OF RESYNCHRONIZATION THERAPY FOR HEART FAILURE IN PATIENTS WITH A QRS DURATION GREATER THAN 120 MS (GREATER-EARTH) STUDY

被引：0
|
作者：
Thibault, B.
Ducharme, A.
Harel, F.
White, M.
O'Meara, E.
Roy, D.
Dubuc, M.
Gagne, P.
Guerra, P. G.
Macle, L.
Rivard, L.
Talajic, M.
Khairy, P.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2010年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123D / 123D
页数：1
相关论文
共 50 条
  • [31] RELATION BETWEEN SUBMAXIMAL EXERCISE TEST AND QUALITY OF LIFE IN PATIENTS WITH RESYNCHRONIZATION THERAPY : A SUBSTUDY OF THE GREATER-EARTH TRIAL
    Spaziano, M.
    Frasure-Smith, N.
    Dubuc, M.
    Khairy, P.
    Guerra, P.
    Macle, L.
    Rivard, L.
    Talajic, M.
    Andrade, J.
    Thibault, B.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S111 - S112
  • [32] Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study)
    Tan, Eugene S. J.
    Lim, Joevy
    Chan, Siew Pang
    Seow, Joshua Tze-Kiat
    Singh, Devinder
    Yeo, Wee Tiong
    Lim, Toon Wei
    Kojodjojo, Pipin
    Seow, Swee-Chong
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (06): : 899 - 906
  • [33] SURVIVAL BENEFIT FROM CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH BORDERLINE QRS DURATION
    Oyenuga, Olusegun
    Habib, Phillip
    Tanaka, Hidekazu
    Haberman, Stephanie C.
    Adelstein, Evan C.
    Saba, Samir
    Gorcsan, John, III
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [34] LIMITATIONS OF RESYNCHRONIZATION THERAPY IN PATIENTS WITH NARROW QRS: INSIGHTS FROM THE EARTH TRIAL
    Thibault, B.
    Dubuc, M.
    Dyrda, K.
    Guerra, P. G.
    Macle, L.
    Rivard, L.
    Roy, D.
    Talajic, M.
    Khairy, P.
    CARDIOLOGY, 2013, 125 : 107 - 107
  • [35] Prerenal failure and response to cardiac resynchronization therapy: Making a case for the sicker patients deriving greater benefit?
    John, Roy M.
    HEART RHYTHM, 2010, 7 (12) : 1783 - 1784
  • [36] Comparative Effectiveness of Cardiac Resynchronization Therapy in Combination With Implantable Defibrillator in Patients With Heart Failure and Wide QRS Duration
    Bilchick, Kenneth C.
    Stukenborg, George J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (10): : 1537 - 1542
  • [37] Sensitivity and specificity of using QRS duration to predict chronic benefit in heart failure patients with cardiac resynchronization therapy
    Yu, Y
    Lamp, B
    Butter, C
    Auricchio, A
    Kloss, M
    Trautman, S
    Kirkels, H
    Stellbrink, C
    EUROPEAN HEART JOURNAL, 2002, 23 : 414 - 414
  • [38] Should Cardiac Resynchronization Therapy Be Used in Patients With Class I-II Heart Failure and a Wide QRS? Cardiac Resynchronization Therapy for Mild Heart Failure The Time Has Come Response
    Tang, W. H. Wilson
    Francis, Gary S.
    CIRCULATION, 2011, 123 (02) : 202 - 202
  • [39] Effectiveness of resynchronization therapy in patients with severe chronic heart failure with QRS complex duration between 120 and 150 msec
    Atroshchenko, E. S.
    Ostrovskiy, Y. P.
    Romanovskiy, D. V.
    Koshlataya, O. V.
    Sidorenko, I. V.
    Shumavets, V. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 355 - 355
  • [40] Response to Cardiac Resynchronization Therapy in Patients with Heart Failure and Renal Insufficiency
    Adelstein, Evan C.
    Shalaby, Alaa
    Saba, Samir
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (07): : 850 - 859
12345